Bruno Sarmento

Nanoparticles reshaping graft-versus-host disease landscape.

Graft-versus-host disease (GVHD) is a major immune-mediated complication of allogeneic hematopoietic stem cell transplantation and remains the leading cause of non-relapse mortality. Glucocorticosteroids are the first-line treatment; however, there is a critical need for more effective and less toxic alternatives. Nano...